Cellectis: Monthly Information on Share Capital and Company … – Business Wire (press release)

Cellectis: Monthly Information on Share Capital and Company … – Business Wire (press release)

Cellectis: Monthly Information on Share Capital and Company …
Business Wire (press release)
Cellectis is a biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART). The company's mission is to …

and more »

Cellectis: Monthly Information on Share Capital and Company … – Business Wire (press release)